Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Sangamo Therapeutics, Inc.
Jul 2, 2019
SGMO Retrace
1
Grab this chart
Grab this chart
SGMO will retrace slightly before its FDA approval, still trading above 100 EMA, MFI/RSI cooling off.
WallStreetCharts
Follow
Also on:
Technical Indicators
WallStreetCharts
Follow
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.